2-Acetamido-2-deoxy-3-O-(alpha-L-fucopyranosyl)-D-glucopyranose

Catalog No. :
ACEPSL219
CAS No. :
24876-86-6
Molecular Formula :
C14H25NO10
Molecular Weight :
367.35

IUPAC Name:N-((2S,3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

2-Acetamido-2-deoxy-3-O-(alpha-L-fucopyranosyl)-D-glucopyranose structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Acetamido-2-deoxy-3-O-(alpha-L-fucopyranosyl)-D-glucopyranose
IUPAC NameN-((2S,3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide
Molecular FormulaC14H25NO10
Molecular Weight367.35
SMILESCC(=O)N[C@@H]1[C@@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](CO)O[C@@H]1O
InChI KeyTUXVLTYUDHJDAL-BGWULCETSA-N
SynonymALPHA-L-FUC-[1->3]-D-GLCNAC;2-ACETAMIDO-2-DEOXY-3-O-(A-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE;2-ACETAMIDO-2-DEOXY-3-O-(ALPHA-L-FUCOPYRANOSYL)-D-GLUCOPYRANOSE;FUC1-A-3GLCNAC;2-acetamido-2-deoxy-3-O-A-L-*fucopyranosyl-D-gluc;2-ACETAMIDO-2-DEOXY-3-O-A-L-FUCOPYRANOSY L-D-GLUCOP;α-3-fucosyl-n-acetylglucosamine;α-l-fuc-(1→3)-d-glcnac
CAS No.24876-86-6

Synthetic Route by SureRoute

1. ACEPSL219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEPSL219 route product structure diagram
    ACEPSL21924876-86-6
Inquiry

2. ACEPSL219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEPSL219 route product structure diagram
    ACEPSL21924876-86-6
Inquiry

Comments (0)